We utilized a large population of samples, over 600 CRC cases, to identify and validate a gene expression biomarker, ZC3H12A (zinc finger CCCH-type containing 12A), for prediction of stage I CRC. The gene discussed is ZC3H12A; the disease is colorectal carcinoma.